SPP-037
SPP-037 is an orally active selective inhibitor of ST6GAL1, with an IC50 of 3.59 μM. It exhibits anti-migration activity against MDA-MB-231 cells by inhibiting integrin α2,6-sialylation and the integrin-FAK-paxillin pathway. In MDA-MB-231 xenograft mouse models, SPP-037 demonstrates antitumor properties. This compound is applicable in breast cancer research.
Product Specifications
Field of Research
Cardiovascular Research, Metabolism Research, Signal Transduction
Molecular Formula
C36H50ClN3O9S
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
![[1,1'-Biphenyl]-4-amine, N-[1,1'-biphenyl]-4-yl-N-[4- (4-dibenzofuranyl) phenyl]-](https://cdn.genprice.uk/genprice/uk/genprice2.webp)
JH919173 1 Each
[1,1'-Biphenyl]-4-amine, N-[1,1'-biphenyl]-4-yl-N-[4- (4-dibenzofuranyl) phenyl]-
Sign In for Pricing
View Details 
TQB16486-01 100 mg
3-Cyclopropyl-1-phenyl-6- (propan-2-yl) -1H-pyrazolo[3,4-b]pyridine-4-carboxylic acid
Sign In for Pricing
View Details TQB16486-02 1 g
3-Cyclopropyl-1-phenyl-6- (propan-2-yl) -1H-pyrazolo[3,4-b]pyridine-4-carboxylic acid
Sign In for Pricing
View Details